Resonac Holdings (4004.T) — 2022Q4 FY2022 Earnings Call Analysis

Operating Losses Hit JPY 14B While 2025 Margin Targets Remain Anchored

Management withdrew full-year guidance yet kept 2025 targets unwavering despite a JPY 14 billion Q1 loss forecast.

Thesis: Resonac is a leveraged chemical conglomerate masquerading as a semiconductor materials play. The 8-point margin expansion bridge to 2025 is a mathematical fantasy. Internal inventory is ballooning while customers destock. This divergence combined with high debt makes the stock a primary short candidate.

Verdict: SHORT — Conviction: HIGH

Catalyst: Realization of the JPY 14 billion Q1 operating loss and potential debt covenant pressure.

Key Risk: Rapid cyclical recovery in Hard Disk Drive media or faster-than-expected high-multiple asset divestitures.

The Tell: CFO Somemiya admitted his tone was 'considerably different' from CEO Takahashi's. This confirms the internal disconnect between the 'vision' and the 'grim' accounting reality.

Detected Patterns

Say/Do Gap: Management keeps 2025 targets while withdrawing 2023 guidance and forecasting immediate operating losses.
Inventory Divergence: Resonac inventories 'increased substantially' while customers are in 'large-scale inventory adjustment.' The channel is stuffed.

Friction Level: HIGH_FRICTION — The achievability of the 2025 20% EBITDA margin target. The bull sees a cyclical bottom in hard disk media and a restructuring payoff. The bear sees a debt-laden chemical conglomerate in structural denial with ballooning inventory and no AI leverage.

Report not found

The report data is no longer available. Please return to the archive.